North America urinalysis market is projected to grow by 6.3% annually in the forecast period and reach $1,973.2 million by 2031, driven by the growing geriatric population, the prevalence of age-related diseases, the growing healthcare expenditure, and the advancing diagnostic technologies.
Highlighted with 23 tables and 47 figures, this 99-page report “North America Urinalysis Market 2021-2031 by Product Type (Instruments, Consumables), Test Type (Biochemical, Pregnancy & Fertility, Sediment), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire North America urinalysis market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America urinalysis market in every aspect of the classification from perspectives of Product Type, Test Type, Application, End User, and Country.
Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
o Automated Analyzer
o Semi-automated Analyzer
o Point-of-Care Analyzer
• Consumables
o Reagents & Kits
o Dipsticks
o Disposables
Based on Test Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Biochemical Test
• Pregnancy & Fertility Test
• Sediment Test
By Applications, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pregnancy & Fertility
• Urinary Tract Infections (UTI)
• Diabetes
• Kidney Diseases
• Liver Diseases
• Other Applications
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals and Clinics
• Diagnostic Laboratories
• Home Care Settings
• Research Laboratories & Institutes
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Test Type and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
77 Elektronika Kft.
Abbott Laboratories
Acon Laboratories Inc.
Arkray Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
Cardinal Health Inc.
Danaher Corporation (Beckman Coulter Inc.)
Eiken Chemical Co., Ltd.
F Hoffmann-La Roche Ltd.
Mindray Medical International Limited
Quidel Corporation
Siemens Healthineers AG
Sysmex Corporation
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
